Your browser doesn't support javascript.
loading
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.
Chu, Charles C; Catera, Rosa; Zhang, Lu; Didier, Sebastien; Agagnina, Briana M; Damle, Rajendra N; Kaufman, Matthew S; Kolitz, Jonathan E; Allen, Steven L; Rai, Kanti R; Chiorazzi, Nicholas.
Affiliation
  • Chu CC; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish (LIJ) Health System, Manhasset, NY 11030, USA. cchu@nshs.edu
Blood ; 115(19): 3907-15, 2010 May 13.
Article in En | MEDLINE | ID: mdl-20110421
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Apoptosis / Nonmuscle Myosin Type IIA / Antibodies, Neoplasm Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Apoptosis / Nonmuscle Myosin Type IIA / Antibodies, Neoplasm Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States